AstraZeneca has launched a strategic partnership with the NASSCOM IoT Centre of Excellence to set up an accelerator programme to support Indian startups develop new innovative solutions to Non-Communicable Diseases (NCD) care in India and beyond.
This opportunity will be open for companies or individuals who are working in the therapeutic areas like diabetes, cardiovascular, cancer/ oncology or respiratory with special focus on thematic areas such as digital solutions, diagnosis and devices.
Under this collaboration, AstraZeneca and NASSCOM will incubate startups in bringing innovative and frugal solutions that can help in the management of NCDs.
Selected startups will have access to NASSCOM’s innovation labs, development resources, cloud services and mentoring support from NASSCOM and AstraZeneca including the opportunity to showcase their innovations in national and global platforms where the latter can showcase their products or services.
At the India-Sweden Unnati healthcare 2.0 day, the company and its partners, Business Sweden, The National Association of Software and Services Companies (NASSCOM), Atal Innovation Mission-Niti Aayog and AGNIi, announced the finalists of the Unnati Healthcare Innovation Challenge. The finalists are: Agasta Software, ChironX, MedloTek Health Systems, Pathsodh Healthcare, Break, Predible Health, ten3T Healthcare and Yostra Labs.
The Unnati Healthcare Innovation Challenge, a first of its kind, was launched in November 2018 to accelerate innovative technologies that can provide affordable and accessible solutions for early screening and management of NCDs such as remote screening methods, point of care diagnostics and digital solutions that enable efficient data capture. As part of this challenge, 90+ healthcare start-ups participated from all over India.
The selected winners among the finalists will be receiving mentorship support from AstraZeneca, which will contribute its unique healthcare domain expertise with the aim of helping the finalists bring their solutions to market.
Commenting on these initiatives, Leif Johansson, Chairman of the Board, AstraZeneca said, “As a science-led organisation, AstraZeneca is committed to strengthen innovation in healthcare in India. We are pleased to collaborate with the government, startup eco-system and industry partners to achieve the shared vision of making meaningful interventions in improving the lives of patients impacted by Non-Communicable diseases in India.”
Echoing similar sentiments, Debjani Ghosh, President, NASSCOM said, “We are pleased to collaborate with them to set up an accelerator programme at the NASSCOM Centre of Excellence for IoT in developing groundbreaking solutions to improve NCD care in India.”
Carsten Gronblad, Trade Commissioner of Sweden to India said, “UNNATI is a model for co-innovation allowing industry, startups and the civil society to jointly develop solutions addressing global social needs. We are happy to partner with AstraZeneca, AGNIi and Atal Innovation Mission – NITI Aayog, with a shared vision of providing affordable and accessible healthcare.”